Medicare physician fee schedule changes
In this table, we highlight some of the forthcoming changes to the Medicare Physician Fee Schedule (PFS) from the Centers for Medicare & Medicaid Services (CMS).
Access to dermatologic care varies by demographic
Outpatient dermatology services can be available to any patient. However, according to recent research, that doesn’t mean all patients access or take advantage of this clinical care in the same way.
Digital tools impact daily dermatology practice
Robot dermatologists aren’t yet seeing patients for routine care, but artificial intelligence (AI) and other technology tools are growing in popularity throughout the industry. Learn more about how these advances in technology are impacting practices.
AAD updates cutaneous melanoma guidelines
Treatment options for metastatic melanoma have greatly improved, including in the adjuvant setting, and these advances are reflected in the recently updated American Academy of Dermatology clinical guidelines on the management of primary cutaneous melanoma. Find out what has changed in this article.
Artificial Intelligence. Friend or foe of dermatology?
Artificial intelligence (AI) tools are steadily growing in popularity throughout medicine, particularly in dermatology. But does AI pose a threat to dermatologists? Find out in this article.
Improving the reporting of social media recruitment for clinical trials
In this article, Katja Reuter, Ph.D. critiques a study by Katz and colleagues on the effectiveness of using digital platforms to recruit for an atopic dermatitis study.
Warning signs of life-threatening purpura
Do you know the warning signs of life threatening purpura? Dr. Roderick Hay outlines what you need to know about potentially life-threatening conditions involving purpura.
Optimize clinical trial recruitment with digital platforms
Digital recruitment for clinical studies may be more effective than traditional methods, according to a new study.
Digital health and dermatology
What exactly is digital health? Dr. Steve Xu tackles this question in this month's Innovation column.
The future of dermatology
In this article, we take a look at the future of dermatology, including the rise of medical devices and drug costs.
FDA says start with pediatric patients in atopic dermatitis trials
The FDA has reversed a long-standing guidance stating that sponsors of clinical trials for atopic dermatitis (AD) in pediatrics need not start the trial in adults first. Here's what you need to know.
Fast-track designation for atopic dermatitis drug
Asana BioSciences announced that the U.S. Food and Drug Administration granted fast-track designation for the investigational ASN002, an oral treatment for moderate-to-severe atopic dermatitis. Learn more in this article.
FDA approves Sandoz's third biosimilar
Sandoz, a division of Novartis, announced that the U.S. Food and Drug Administration approved its biosimilar, adalimumabadaz (Hyrimoz, Novartis AG).
A look at drug development from bench to pharmacy
The cost of clinical trials to get a dermatology drug to market may cost as much as $25 million, which is slightly above a median of $19 million, according to the latest research.
AAD annual meeting starts March 1
The American Academy of Dermatology annual meeting will be held from March 1-5 in Washington, D.C.
Laundry soap earns stamp of approval for sensitive skin
The National Psoriasis Foundation and the National Eczema Association have awarded Procter & Gamble’s Tide Free and Gentle Liquid Laundry Detergent and Tide PODS Free and Gentle Laundry Detergent a “Seal of Recognition” and “Seal of Acceptance” for people with eczema or sensitive skin.
How social media can lead to a HIPAA violation
When can a physician disclose protected health care information? Dr. David J. Goldberg addresses this question in this month's Legal Eagle column.
Defining success in dermatology
In this article, Dr. Ronald G. Wheeland offers his point of view on how to define success in dermatology.
Cleanser mildness concepts explained
In this month's Cosmetic Conundrums, Dr. Draelos explains cleanser mildness, the chemical characteristics of mild cleansers and how these cleansers are tested.
2 Clarke Drive Cranbury, NJ 08512